Infosys Ltd ADR (INFY) was Downgraded by Credit Suisse to ” Neutral”. Earlier the firm had a rating of “Outperform ” on the company shares. Credit Suisse advised their investors in a research report released on Jul 18, 2016.
Many Wall Street Analysts have commented on Infosys Ltd ADR. Infosys Ltd ADR was Downgraded by Nomura to ” Neutral” on Jul 18, 2016. Infosys Ltd ADR was Initiated by Pacific Crest to “Sector Weight” on Jul 12, 2016. Infosys Ltd ADR was Upgraded by Goldman to ” Buy” on May 26, 2016.
On the company’s financial health, Infosys Ltd ADR reported $15.03 EPS for the quarter, missing the analyst consensus estimate by $ -0.11 based on the information available during the earnings call on Jul 15, 2016. Analyst had a consensus of $15.14. The company had revenue of $167820.00 million for the quarter, compared to analysts expectations of $170687.00 million. The company’s revenue was up 16.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $13.26 EPS.
Infosys Ltd ADR closed down -1.63 points or -8.84% at $16.81 with 2,10,35,810 shares getting traded on Friday. Post opening the session at $16.86, the shares hit an intraday low of $16.51 and an intraday high of $17.09 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
Infosys Limited is engaged in consulting technology outsourcing and next-generation services. The Company’s solutions include application development and maintenance independent validation services infrastructure management engineering services comprising product engineering and life cycle solutions and business process management; Management Consulting enterprise solutions and package implementation systems integration and business intelligence; Products business platforms and solutions and technologies such as cloud computing enterprise mobility digital big data and analytics. Its segments are Financial Services and Insurance Manufacturing Energy and utilities Communication and Services Retail Consumer packaged goods and Logistics Life Sciences and Healthcare and Growth Markets.